Research Ⅱ on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs: The Enlightenment of EU Requirements for Drug Clinical Trials and Change Management during Clinical Trials on Improving China's Regulatory System

Wang Hongyang, Chen Jiangpeng, Gu Yaohua, Lu Chenshu, Xia Yu, Lian Zhirong, Wu Zhengyu

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (5) : 499-507.

PDF(876 KB)
PDF(876 KB)
Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (5) : 499-507. DOI: 10.16153/j.1002-7777.2024.05.002
Supervision & Administration: Research on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs

Research Ⅱ on the Changes of Sponsors and Production Sites during the Clinical Research Phase of Drugs: The Enlightenment of EU Requirements for Drug Clinical Trials and Change Management during Clinical Trials on Improving China's Regulatory System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(5): 499-507 https://doi.org/10.16153/j.1002-7777.2024.05.002

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(876 KB)

Accesses

Citation

Detail

Sections
Recommended

/